Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #194816 on Avid Bioservices Inc (CDMO)
InternetForumUser
10/22/14 7:16 PM
#194827 RE: edcpf #194816
"A Phase Ib IST evaluating bavituximab in combination with carboplatin and pemetrexed in up to 25 patients with previously untreated Stage IV NSCLC has completed enrollment with interim data accepted for presentation at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology to be held October 30 - November 1, 2014."